Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 77

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 15
Chunk 77
---
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

(a) 1. Financial Statements:

The following consolidated financial statements of the Company are set forth in Part II, Item 8:

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2024 and 2023 

Consolidated Statements of Income for the years ended December 31, 2024, 2023, and 2022 

Consolidated Statements of Comprehensive Income for the years ended December 31, 2024, 2023, and 2022 

Consolidated Statements of Cash Flows for the years ended December 31, 2024, 2023 and 2022 

Consolidated Statements of Shareholders’ Equity for the years ended December 31, 2024, 2023 and 2022 

Notes to Consolidated Financial Statements

 2. Financial Statement Schedule:

The following financial statement schedule of the Company is included in Item 15(c):

Schedule II—Condensed Financial Information of Registrant (Parent Company Only).

All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions, are inapplicable, or the required information is included in the consolidated financial statements, and therefore, have been omitted.

 3. Exhibits required to be filed as part of this report:

ExhibitNumberExhibit3.1Amended and Restated Articles of Incorporation of the Company, as amended and restated effective June 27, 2022, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 28, 2022.3.2Bylaws of the Company, as amended effective October 4, 2023, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 5, 2023.4.1Indenture, dated as of December 9, 2004, between the Company and The Bank of New York Trust Company, N.A., as trustee, including the Form of the Company’s 5.950% Notes due 2034, incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on December 15, 2004.4.2Indenture, dated as of January 10, 2006, between the Company and